Lifetime management of patients with severe aortic stenosis - Securing long-term benefits
Sponsored by Boston Scientific
TAVI
Interventions for Valvular Disease
Join us if you want
- To learn about lifetime management of patients with aortic stenosis
- To understand the importance of the heart team in patient specific treatment
- To understand how procedural refinement may optimise long-term outcomes
Anchorperson: Lars Sondergaard
Moderator: Darren Mylotte
Discussants: Francesco Bedogni, Lenard Conradi, Won-Keun Kim
Chatmaster: Ahmed M ElGuindy
Session objectives
Lars Sondergaard
Case presentation
Francesco Bedogni
Discussion and audience interaction
Who are at risk for early valve failure and how to avoid this?
Lenard Conradi
Discussion and audience interaction
What is the need for coronary access after TAVI and is it possible?
Won-Keun Kim
How to secure coronary access after TAVI
Darren Mylotte
Discussion and audience interaction
Will new onset conduction abnormalities impact the patient outcomes and how can we reduce the risk?
Lars Sondergaard
Discussion and audience interaction
Recorded case from IRCCS Policlinico San Donato - Milan, Italy
Francesco Bedogni
Discussion and audience interaction
Session evaluation and key learnings
Lars Sondergaard
